Condition: Vaginal Stenosis · Radiation Therapy · Cancer · Sponsor: Hyivy Health Inc
Vaginal dilator therapy (VDT) with static dilators is often prescribed to patients following vaginal or pelvic radiation therapy. This study seeks to evaluate the feasibility of a novel intravaginal device that delivers patient-controlled dilation (Hyivy device). The study is designed as a proof-of-concept single-arm pilot study. The primary objective is to assess safety and tolerability, while also evaluating changes in health-related quality of life and pelvic pain.
This description comes directly from the study's public registry record.
Daniel Glick, MD · (519) 749-4370 · Daniel.Glick@grhosp.on.ca
Always discuss trial participation with your own doctor first.
| Grand River Regional Cancer Centre, Waterloo Regional Health Network @ Midtown | Kitchener, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05648253